Summary
The time course of radioactivity in plasma and the excretion in urine and faeces over 7 days were determined in 12 healthy subjects after single oral and intravenous doses of a solution of3H-β-methyldigoxin. 62.2±2.1 and 29.0±5.2 per cent of the dose were excreted in urine and faeces, respectively, within 7 days of intravenous administration, compared with 55.2±2.8 and 28.6±5.7 per cent after oral administration. This indicates almost complete absorption of the glycoside when given in solution. 12 hours after its administration a pseudo-distribution equilibrium was reached and the average half life of tritiated compounds was 1.3 days. By 48 – 96 hours after treatment the average half life was 2.8 days. O-demethylation was revealed as the main metabolic degradation step in man. The rate of Demethylation was higher after oral than i.v. administration. Thus, only 31% of the radioactivity excreted in the urine consisted of unchanged β-methyldigoxin after oral administration compared to 51% after i.v. dosing. Only traces of bis- and monoglycosides were excreted in urine, but there were considerable amounts in faeces, where they accounted for more than 35% of the total excretion. Up to 40% of the radioactivity in plasma and urine consisted of polar conjugates during the first 12 hours after administration of β-methyldigoxin. The mono- and bisglycosides were identified as the main products of conjugation. During the 7 days approximately 15% of the administered dose was metabolized by splitting off glycosidic bonds and conjugation to polar compounds.
Similar content being viewed by others
References
Abshagen, U., Rennekamp, H., Küchler, R., Rietbrock, N.: Formation and disposition of bisand monoglycosides after administration of3H-4‴-methyldigoxin to man. Europ. J. clin. Pharmacol.7, 177–181 (1974)
Abshagen, U., Rietbrock, N.: Metabolism of digoxigenin, digoxigeninmonodigitoxoside and digoxigeninbisdigitoxoside in rats. Naunyn-Schmiedeberg's Arch. Pharmacol.276, 157–166 (1973)
Bergmann, K.v., Abshagen, U., Rietbrock, N.: Quantitative analysis of digoxin, 4‴-acetyldigoxin and 4‴-methyldigoxin and their metabolites in bile and urine of rats. Naunyn-Schmiedeberg's Arch. Pharmacol.273, 154–167 (1972)
Bine, R., Friedmann, M., Byers, S.O., Bland, C.: The deposition of digitoxin in the tissues of the rat after parenteral injection. Circulation4, 105–107 (1951)
Blankart, R.: Zum Verhalten der Herzglykoside im meschlichen Organismus. Eine Übersicht am Beispiel des Digoxins und des Lanatosid C. Ther. Umsch.28, 205–211 (1971)
Chiou, W.L.: A simple equation to estimate the fraction of drug remaining in the body after an intravenous injection. J. Pharm. Pharmacol.34, 342–343 (1972)
Dengler, H.J., Bodem, G., and Wirth, K.: Pharmakokinetische Untersuchungen mit3H-Digoxin und3H-Lanatosid beim Menschen. Arzneimittel-Forsch. (Drug Res.)23, 64–74 (1973)
Doherty, J.E.: The clinical pharmacology of digitalis glycosides: A review. Amer. J. med. Sci.255, 382–414 (1968)
Fischer, C.S., Sjoerdsma, A., Johnson, R.: The tissue distribution and excretion of radio-active digitoxin. Circulation5, 496–503 (1952)
Friedman, M., George, S.St., Bine, R., Byers, S.O., Bland, C.: Deposition and disappearance of digitoxin from the tissues of the rat, rabbit, and dog after parenteral injection. Circulation6, 367–370 (1952)
Garret, E.R.: The clinical significance of pharmacokinetics. Pharmacological and clinical significance of pharmacokinetics. Stuttgart-New York: F.K. Schattauer-Verlag 1970
Herrmann, I., Repke, K.: Konjugation von Cardenolid-geninen mit Schwefelsäure oder Glucuronsäure. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.248, 370–386 (1964)
Kaiser, F.: Die papierchromatographische Trennung von Herzgiftglykosiden. Chem. Ber.88, 556–563 (1955)
Kramer, P., Horenkamp, J., Willms, B., Scheler, F.: Das Kumulationsverhalten verschiedener Herzglykoside bei Anurie. Dtsch. med. Wschr.95, 444–453 (1970)
Kuhlmann, J., Abshagen, U., Rietbrock, N.: Cleavage of glycosidic bonds of digoxin and derivatives as function of pH and time. Naunyn-Schmiedeberg's Arch. Pharmacol.276, 149–156 (1973)
Kuhlmann, J., Abshagen, U., Rietbrock, N.: Pharmacokinetics and metabolism of digoxigeninmonodigitoxoside in man. Europ. J. clin. Pharmacol.7, 87–94 (1974)
Repke, K.: Verteilung, Ausscheidung und Stoffwechsel von Digitoxin bei der Ratte. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.233, 271–283 (1958)
Repke, K.: Stoffwechsel und Wirkung von Digitalisglykosiden. Öst. Apoth.-Ztg.24, 515–522 (1970)
Rietbrock, N., Rennekmap, Ch., Rennekmap, H., Bergmann, K.v., Abshagen, U.: Demethylation and cleavage of glycosidic bonds of 4‴-methyldigoxin in man. Naunyn-Schmiedeberg's Arch. Pharmacol.272, 450–453 (1972a)
Rietbrock, N., Abshagen, U., Bergmann, K.v., Kewitz, H.: Pharmacokinetics of digoxin and its 4‴-acetyl- and methyl-derivates in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol.274, 171–181 (1972b)
Rietbrock, N., Abshagen, U.: Stoffwechsel und Pharmakokinetik der Lanataglykoside beim Menschen. Dtsch. med. Wschr.98, 117–122 (1973)
Rietbrock, N., Guggenmos, J., Kuhlmann, J., Hess, U.: Bioavailability and pharmacokinetics of β-methyldigoxin after multiple oral and intravenous doses. Europ. J. clin. Pharmacol. (submitted for publication).
Ruiz-Torres, A., Burmeister, H.: Stoffwechsel und Kinetik von β-Acetyldigoxin. Klin. Wschr.50, 191–195 (1972)
Vöhringer, H.F., Rietbrock, N.: Metabolism and excretion of digitoxin in man. Clin. Pharmacol. Ther.16, 796–806 (1974)
Voigtländer, W., Schaumann, W., Koch, K., Zielske, F.: β-Methyl-Digoxin. IV. Blood levels, tissue distribution and metabolism in the guinea pig. Naunyn-Schmiedeberg's Arch. Pharmacol.272, 46–64 (1972)
Weissler, A.M., Lewis, R.P., Leighton, R.F., Bush, Ch. A.: Comparitive responses to the digitalis glycosides in man. ‘Basic and clinical pharmacology of digitalis’ (eds. Marks & Weissler), p. 260. Springfield, Illinois: C.C. Thomas 1972
Wirth, K., Bodem, G., Dengler, H.J.: Kinetik und Stoffwechsel von Digoxin und verwandten Herzglykosiden beim Menschen. Naunyn-Schmiedeberg's Arch. Pharmacol.269, 427–428 (1971)
Wirth, K., Bodem, G., Dengler, H.J.: Resorption, Ausscheidung und Stoffwechsel von Digoxin und digoxinverwandten Verbindungen. Aktuelle Digitalisprobleme (eds. R. Schröder and K. Greeff), München-Berlin-Wien: Urban & Schwarzenberg 1972
Zilly, W., Richter, E., Rietbrock, N.: Pharmacokinetics and metabolism of digoxin- and β-methyldigoxin-12α-3H in patients with acute hepatitis. Clin. Pharmacol. Ther.17, 302–309 (1975)
Author information
Authors and Affiliations
Additional information
Supported by the Deutsche Forschungsgemeinschaft and by Boehringer Mannheim, Germany
Rights and permissions
About this article
Cite this article
Rietbrock, N., Abshagen, U., v. Bergmann, K. et al. Disposition of β-methyldigoxin in man. Eur J Clin Pharmacol 9, 105–114 (1975). https://doi.org/10.1007/BF00614005
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00614005